Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 24 to 28, 2022. This …
Three mRNA Vaccine Doses Protective Against Delta, Omicron
However, odds ratios were higher for omicron suggesting that booster doses are less protective than against delta
Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant
The variant, called BA.2, has genetic traits that make it somewhat more difficult to detect
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
Other U.S. hospitals have also faced criticism for denying transplants to patients who were not vaccinated against COVID-19
Alterations in Gut Microbiome ID’d in Postacute COVID-19 Syndrome
Higher levels of Ruminococcus gnavus, Bacteroides vulgatus, lower levels of Faecalibacterium prausnitzii observed in patients with PACS
COVID-19 Vaccination Not Linked to Fecundability in Men, Women
SARS-CoV-2 infection associated with short-term transient decline in fertility for men
Omicron Linked to Increase in COVID-19 Cases, Lower Disease Severity
Mean length of stay and percentages admitted to ICU, receiving invasive mechanical ventilation, dying lower during omicron
Third mRNA Vaccine Dose Ups Effectiveness Against Hospitalization
Vaccine effectiveness against COVID-19 hospitalization increased with third dose in those with, without immunocompromising conditions
Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
For asymptomatic SARS-CoV-2-positive individuals living with infected household contact, combo cuts incidence of symptomatic COVID-19